FCGR3A 158V/F polymorphism and response to frontline R-CHOP therapy in diffuse large B-cell lymphoma.
about
Scientific rationale for extrapolation of biosimilar data across cancer indications: case study of CT-P10.Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma.Fcγ receptors: genetic variation, function, and disease.FcγR requirements leading to successful immunotherapy.The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis.
P2860
FCGR3A 158V/F polymorphism and response to frontline R-CHOP therapy in diffuse large B-cell lymphoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@ast
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@en
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@nl
type
label
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@ast
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@en
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@nl
prefLabel
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@ast
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@en
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
FCGR3A 158V/F polymorphism and ...... diffuse large B-cell lymphoma.
@en
P2093
Huirong Ding
Lijuan Deng
Yuqin Song
P2860
P304
P356
10.1089/DNA.2013.2333
P577
2014-07-22T00:00:00Z